Thailand invests 2.4 B baht in new biotech projects Thailand invests 2.4 B baht in new biotech projects 06 April 2021 | News The biotechnology sector is part of the so-called BCG model (Bio, Circular and Green economy) which the Thai government has set as a priority to lead the post-COVID-19 recovery Image credit- prnasia The Thailand Board of Investment (BOI) has recently approved new projects in the field of advanced biotechnology, worth a combined 2.4 billion baht (around $78 million) in investment, reflecting the increased interest of local and foreign investors in the country's biotech sector. Thai Kyowa Biotechnologies, a producer of amino acids for pharmaceuticals affiliated to Japan's Kirin Holdings, received approval for an advanced biotech project to produce Human Milk Oligosaccharide (HMO), a prebiotic and key ingredient in milk powder for infants and adults, helping to build immunity.